Registry update — unassessed
Novel Actions of Metformin to Augment Resistance Training Adaptations in Older Adults
Trial registry update: COMPLETED. Results are posted in the registry; assessment pending.
RCTNotable significance
What this changes
The finding has not established an approved change to our evidence assessment.
Source date: Sep 17, 2019 · Discovered: Sep 15, 2026 · Assessed: — · Historical research backfill
What it does not prove
- Whether metformin actually enhanced muscle mass or strength gains cannot be assessed, as results are not provided in the abstract
- The study design and population are unclear without sample size, age range, duration, and outcome measures
- Generalisability to other populations or dose-response effects cannot be determined from this incomplete report
Extracted from supplied source material; model confidence is not a measured probability of correctness.
Study details
- Design
- Rct
- Sample size
- —
- Duration
- —
- Population
- Older adults
- Primary outcome
- Muscle mass and strength gains during resistance training
- Effect size
- —
- Significance
- Not reported
- Journal
- Philip Kern
- Published
- Sep 17, 2019
Sources
Primary source
- Philip Kern ↗Clinical trial
Recorded source passages
Abstract or registry material supplied for assessment; source version 1. This is not a claim of full-text review.
Title: Novel Actions of Metformin to Augment Resistance Training Adaptations in Older Adults
The purpose of this study is to determine whether a commonly prescribed drug, metformin, can enhance the benefits seen during resistance exercise such as increased muscle mass and strength.
Source versions
Assessment history
Discussion (0)
One thread per scientific event, no matter how many outlets covered it.
Sign in to join the discussion.
No comments yet
Be the first to weigh in on this evidence.